Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (361-370 of 544) with videos related to

Pageof 55
Sort By:
The Pediatric Infectious Disease Journal|October 18, 2011
The hidden costs and characteristics of childhood rotavirus emergency visits in CanadaNicole Le Saux, Julie Bettinger, Pierre Déry, et al.
Journal of Medicinal Chemistry|April 2, 2004
3,3-diaryl-1,3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibitionAmarnath Natarajan, Yun-Hua Fan, Han Chen, et al.
Vaccine|October 15, 2010
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of ageScott A Halperin, Anil Gupta, Robert Jeanfreau, et al.
Vaccine|August 21, 2012
A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccineBrenda L Coleman, Allison J McGeer, Scott A Halperin, et al.
American Journal of Hematology|May 15, 2013
A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetesPamela Ghosh, Rupam Sahoo, Anand Vaidya, et al.
BMC Infectious Diseases|April 19, 2018
Contact among healthcare workers in the hospital setting: developing the evidence base for innovative approaches to infection controlKrista M English, Joanne M Langley, Allison McGeer, et al.
Vaccine|February 12, 2023
Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network studyKarsten Hempel, Wade McDonald, Nathaniel D Osgood, et al.
The Pediatric Infectious Disease Journal|March 3, 2006
How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?Scott A Halperin, Lamont Sweet, Darlene Baxendale, et al.
Journal of Clinical Medicine|July 9, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2018
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune ResponseScott A Halperin, Joanne M Langley, Lingyun Ye, et al.
Pageof 55

Showing results (361-370 of 544) with videos related to

Sort By:
Pageof 55
The Pediatric Infectious Disease Journal|October 18, 2011
The hidden costs and characteristics of childhood rotavirus emergency visits in CanadaNicole Le Saux, Julie Bettinger, Pierre Déry, et al.
Journal of Medicinal Chemistry|April 2, 2004
3,3-diaryl-1,3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibitionAmarnath Natarajan, Yun-Hua Fan, Han Chen, et al.
Vaccine|October 15, 2010
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of ageScott A Halperin, Anil Gupta, Robert Jeanfreau, et al.
Vaccine|August 21, 2012
A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccineBrenda L Coleman, Allison J McGeer, Scott A Halperin, et al.
American Journal of Hematology|May 15, 2013
A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetesPamela Ghosh, Rupam Sahoo, Anand Vaidya, et al.
BMC Infectious Diseases|April 19, 2018
Contact among healthcare workers in the hospital setting: developing the evidence base for innovative approaches to infection controlKrista M English, Joanne M Langley, Allison McGeer, et al.
Vaccine|February 12, 2023
Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network studyKarsten Hempel, Wade McDonald, Nathaniel D Osgood, et al.
The Pediatric Infectious Disease Journal|March 3, 2006
How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?Scott A Halperin, Lamont Sweet, Darlene Baxendale, et al.
Journal of Clinical Medicine|July 9, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2018
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune ResponseScott A Halperin, Joanne M Langley, Lingyun Ye, et al.
Pageof 55